EMC Abstracts

Official abstracts site for the European Microscopy Congress

MENU 
  • Home
  • Meetings Archive
    • The 16th European Microscopy Congress 2016
  • Keyword Index
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and Print All Favorites
    • Clear all your favorites
  • Advanced Search

A potential therapeutic effects of BMN673, a novel PARP inhibitor, on Triple Negative Breast Cancer

Abstract number: 5883

Session Code: LS03-049

DOI: 10.1002/9783527808465.EMC2016.5883

Meeting: The 16th European Microscopy Congress 2016

Session: Life Sciences

Topic: Cell functional exploration

Presentation Form: Poster

Corresponding Email: gamzeguney@anadolu.edu.tr

Gamze Guney Eskiler (1), Gulsah Cecener (1), Unal Egeli (1), Berrin Tunca (1)

1. Medical Biology, Uludag University, Bursa, Turquie

Keywords: Apoptosis, BMN673, PARP inhibitors, Triple negative breast cancer (TNBC)

Triple negative breast cancer (TNBC) is the most aggressive and lethal subtype of breast cancer due to a higher rate of early recurrence, distant metastases and also heterogeneity in the molecular levels. Thus, there is a urgent need for effective therapies. In the recent years, PARP inhibitors have drawn considerable attention for especially BRCA-associated sporadic TNBC patients. In the present study, we aimed to determine the cytotoxic and apoptotic effects of BMN 673, which is a novel and highly potent PARP inhibitor,  on TNBC cell line.

Triple-negative BRCA1-defective HCC1937 breast cancer cell line was treated with BMN673 and the cytoxoxicity effects was evaluated by WST-1 analysis. The apoptotic effects was evaluated using Annexin V-propidium iodide (PI) and cell cycle analysis. The double stained with acridine orange/ethidium bromide of these cells was observed under the fluorescence microscope.

Initial cytotoxicity screening showed that BMN673 displayed the anti-proliferative effect, with in time (6-12 days) and dose-dependent (0.01, 0.1, 1 and 10 nM) (p<0.05). The maximum inhibition rate was measured 19.54%, 24.21%, 49.91%  and 58.0% at 0.01, 0.1, 1 and 10 nM of BMN673 at 12 days, respectively (p<0.05). There was an increase of apoptotic cell death and cell cycle progression in all concentrations compared to the untreated control. Treatment with doses of 0.01, 0.1, 1 and 10 nM BMN673 significantly induced total apoptotic cells (6.2%, 23.45%, 47.95% and 61.28%, respectively) and a significant block at the G2/M phase. Additionally, we observed a loss of membrane integrity, chromatin condensation and increasing vacuole formation in HCC1937 cells when treated with the maximum concentration of BMN673.

In conlusion, this study has revealed that BMN673 inhibits cell proliferation and  induces cell cycle progression and apoptosis within the minimum concentration. Thus, BMN673 could represent a potentially therapeutic strategy for especially, BRCA-defective TNBC.

Figures:

Fig.1. The Annexin V/PI results of HCC1937 cells treated with the minimum (0.01 nM) and maximum (10 nM) concentration of BMN673 for 12 days compared with control

Fig. 2. The images of HCC1937 cells. (A) Control, (B) Treated with 0.01 nM BMN673, and (C) 10 nM BMN673.

To cite this abstract:

Gamze Guney Eskiler, Gulsah Cecener, Unal Egeli, Berrin Tunca; A potential therapeutic effects of BMN673, a novel PARP inhibitor, on Triple Negative Breast Cancer. The 16th European Microscopy Congress, Lyon, France. https://emc-proceedings.com/abstract/a-potential-therapeutic-effects-of-bmn673-a-novel-parp-inhibitor-on-triple-negative-breast-cancer/. Accessed: May 17, 2022
  • Tweet
  • Email
  • Print
Save to PDF

« Back to The 16th European Microscopy Congress 2016

EMC Abstracts - https://emc-proceedings.com/abstract/a-potential-therapeutic-effects-of-bmn673-a-novel-parp-inhibitor-on-triple-negative-breast-cancer/

Most Viewed Abstracts

  • mScarlet, a novel high quantum yield (71%) monomeric red fluorescent protein with enhanced properties for FRET- and super resolution microscopy
  • 3D structure and chemical composition reconstructed simultaneously from HAADF-STEM images and EDS-STEM maps
  • Pixelated STEM detectors: opportunities and challenges
  • Layer specific optical band gap measurement at nanoscale in MoS2 and ReS2 van der Waals compounds by high resolution electron energy loss spectroscopy
  • Developments in unconventional dark field TEM for characterising nanocatalyst systems

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Visit Our Partner Sites

The 16th European Microscopy Congress

The official web site of the 16th European Microscopy Congress.

European Microscopy Society

European Microscopy Society logoThe European Microscopy Society (EMS) is committed to promoting the use and the quality of advanced microscopy in all its aspects in Europe.

International Federation of Societies for Microscopy

International Federation of Societies for Microscopy logoThe IFSM aims to contribute to the advancement of microscopy in all its aspects.

Société Française des Microscopies

Société Française des MicroscopiesThe Sfµ is a multidisciplinary society which aims to improve and spread the knowledge about Microscopy.

Connect with us

Imaging & Microscopy
Official Media Partner of the European Microscopy Society.

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2022 John Wiley & Sons, Inc. All Rights Reserved.
Wiley
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.